ACADIA Pharmaceuticals Inc (ACAD.OQ)
ACAD.OQ on NASDAQ Stock Exchange Global Select Market
41.39USD
10:07pm IST
41.39USD
10:07pm IST
Change (% chg)
$-1.21 (-2.84%)
$-1.21 (-2.84%)
Prev Close
$42.60
$42.60
Open
$40.64
$40.64
Day's High
$41.46
$41.46
Day's Low
$40.06
$40.06
Volume
901,812
901,812
Avg. Vol
539,610
539,610
52-wk High
$44.84
$44.84
52-wk Low
$13.94
$13.94
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.41 | December | 18 Sep 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 3 | 1 | 1 | 1 |
| (2) OUTPERFORM | 7 | 7 | 7 | 7 |
| (3) HOLD | 2 | 4 | 4 | 4 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.92 | 2.25 | 2.25 | 2.25 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 11 | 88.24 | 91.53 | 86.00 | 77.75 |
| Quarter Ending Dec-19 | 11 | 92.08 | 95.00 | 90.00 | 82.15 |
| Year Ending Dec-19 | 12 | 326.29 | 329.77 | 320.87 | 317.11 |
| Year Ending Dec-20 | 12 | 452.43 | 693.18 | 362.06 | 599.26 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 11 | -0.41 | -0.37 | -0.44 | -0.41 |
| Quarter Ending Dec-19 | 11 | -0.41 | -0.33 | -0.51 | -0.39 |
| Year Ending Dec-19 | 12 | -1.84 | -1.71 | -2.43 | -1.53 |
| Year Ending Dec-20 | 12 | -1.35 | 0.45 | -2.74 | 0.37 |
| LT Growth Rate (%) | 1 | 26.50 | 26.50 | 26.50 | 22.50 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jun-19 | 72.12 | 83.21 | 11.08 | 15.36 |
| Quarter Ending Mar-19 | 60.69 | 62.96 | 2.27 | 3.74 |
| Quarter Ending Dec-18 | 59.46 | 59.57 | 0.11 | 0.18 |
| Quarter Ending Sep-18 | 56.07 | 58.31 | 2.24 | 3.99 |
| Quarter Ending Jun-18 | 58.63 | 57.06 | 1.57 | 2.68 |
| Earnings (per share) | ||||
| Quarter Ending Jun-19 | -0.45 | -0.38 | 0.07 | -16.39 |
| Quarter Ending Mar-19 | -0.52 | -0.59 | 0.07 | -12.49 |
| Quarter Ending Dec-18 | -0.55 | -0.50 | 0.05 | -9.09 |
| Quarter Ending Sep-18 | -0.58 | -0.50 | 0.08 | -13.49 |
| Quarter Ending Jun-18 | -0.45 | -0.51 | 0.06 | -12.78 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 88.24 | 88.24 | 88.54 | 77.31 | 77.75 |
| Quarter Ending Dec-19 | 92.08 | 92.08 | 91.50 | 80.99 | 82.15 |
| Year Ending Dec-19 | 326.29 | 326.01 | 325.76 | 292.82 | 317.11 |
| Year Ending Dec-20 | 452.43 | 447.77 | 454.14 | 415.01 | 599.26 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | -0.41 | -0.41 | -0.40 | -0.44 | -0.41 |
| Quarter Ending Dec-19 | -0.41 | -0.41 | -0.41 | -0.41 | -0.39 |
| Year Ending Dec-19 | -1.84 | -1.84 | -1.78 | -1.91 | -1.53 |
| Year Ending Dec-20 | -1.35 | -1.37 | -1.20 | -1.19 | 0.37 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-19 | 0 | 0 | 0 | 1 |
| Quarter Ending Dec-19 | 0 | 0 | 2 | 0 |
| Year Ending Dec-19 | 1 | 0 | 2 | 0 |
| Year Ending Dec-20 | 1 | 1 | 3 | 3 |
| Earnings | ||||
| Quarter Ending Sep-19 | 0 | 0 | 0 | 2 |
| Quarter Ending Dec-19 | 1 | 0 | 3 | 1 |
| Year Ending Dec-19 | 1 | 0 | 3 | 2 |
| Year Ending Dec-20 | 1 | 0 | 3 | 6 |
Earnings vs. 
Estimates